Warning letter
Calvin Scott & Company Inc.: warning letter of Jan 21, 2000
FDA warning letter UCM068048 · Denver District Office
Key facts
| Reference number | UCM068048 |
|---|---|
| Company | Calvin Scott & Company Inc. |
| Subject | Prescription Non-prescription Drug Repackaging Relabeling/CGMP |
| Issue date | Jan 21, 2000 |
| Posted date | Jan 21, 2000 |
| Issuing office | Denver District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Albuquerque |
| Inspection ZIP | 87123-2745 |
| Inspection start date | Nov 10, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: